English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Infections due to Varicella-zoster virus (VZV) are common in HIV infected patients (HIVP), yet antibody levels to VZV are not routinely measured. To better understand host-VZV dynamics in HIVP plus assess the clinical utility of a commercial assay, IgG levels were measured and correlated with CD4 count, viral load (VL), history (HX) of Herpes zoster (HZ) and demographics. Methods Specimens were processed using a semi-quantitative assay. Results reported as an index: <135 consistent with “absence of immunity,” 135–165 “equivocal”, and >165 reflected “immunity.” Cut-off point reported as >4000. Statistical computations were performed in the R computing package (R Core Team 2017). Proportions compared using the exact chi-squared test. Highly skewed variables compared using the Mann–Whitney–Wilcoxon test, and censored variables compared via a generalization of MWW (log-rank). Results During 22 months, 426 HIVP enrolled, 284 (66%) males and 142 females; mean age was 44 and 51, respectively. Mean IgG index for all HIVP = 1,886, males = 1,971, females = 1,720 (P = 0.06). However, difference in median IgG was significant (1,730 vs. 1,477; P < 0.0001). Hx of HZ was elicited in 113 (27%), no gender difference (27% vs. 25%, P = 0.55). Frequency of IgG > 4,000 was not significant. HIVP subdivided into 3 age groups for further comparisons. Age≤ = 30: 79 HIVP, 87% of which were males, only 9 (11%) had Hx of HZ, lowest mean IgG = 1,686 and least HIV control. VL< 50 c/mL in 44%. Age 31 to 59: 274 HIVP with mean age of 47, mean IgG = 1,908, and 72% with VL < 50. A Hx of HZ in 86 (31%). Age ≥ 60: 73 HIVP with mean age of 65, mean IgG = 2006. Eighteen had Hx of HZ. Compared with second group, oldest group had better HIV control with VL < 50 in 79% (P = 0.039) yet mean IgG was similar (P = 0.33). Through a logistic regression analysis, the probability of HZ steadily increased as a function of age until about 55. IgG indexes >4,000 were also noted in 58 asymptomatic HIVP. Conclusion Intermittent, asymptomatic VZV reactivation occurs in HIVP regardless of prior HZ. IgG < 135 predicted negative Hx of HZ. Pre-existing IgG may not protect against VZV reactivation. Disclosures All authors: No reported disclosures.

Varicella zoster Virus IgG Antibody Levels in HIV Infected Patients Managed at Ryan White Clinics in Three South Carolina Counties